New infusion device for trans-tissue, sustained local delivery of anticancer agent to surgically resected tissue

Potential use for suppression of local recurrence of pancreatic cancer

Tatsuya Manabe, Hidenobu Okino, Ryo Maeyama, Kazuhiro Mizumoto, Masao Tanaka, Takehisa Matsuda

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Local recurrence is a major cause of death of patients who have undergone resection for pancreatic cancer. To reduce the incidence of local recurrence, a new drug-infusion device, which is fixed on resected tissues immediately after surgery, was devised for trans-tissue, sustained local delivery. The drug-infusion device proposed here has the following functions: tight adhesion of the device on resected tissues, sustained drug infusion to the tissue, drug reloading, and easy removal from the body after use. The fabricated prototype experimental device, described here, was a thin infusion pouch made of a thin elastomer film (segmented polyurethane), which is connected to an elastomeric tube for drug reloading. The suppressive effect of the device delivering the anticancer agent, gemcitabine (GEM), was examined using subcutaneous tumor-bearing athymic mouse. A low-dose, local sustained GEM delivery using the device significantly suppressed the tumor growth and regrowth after surgery. The preliminary model experimental result appears to provide a promising therapeutic procedure for increased survival rate of the patients undergoing surgery for pancreatic cancer.

Original languageEnglish
Pages (from-to)203-207
Number of pages5
JournalJournal of Biomedical Materials Research - Part B Applied Biomaterials
Volume73
Issue number1
DOIs
Publication statusPublished - Apr 1 2005

Fingerprint

Drug infusion
gemcitabine
Antineoplastic Agents
Tissue
Surgery
Tumors
Bearings (structural)
Elastomers
Polyurethanes
Pharmaceutical Preparations
Adhesion

All Science Journal Classification (ASJC) codes

  • Biomaterials
  • Biomedical Engineering

Cite this

@article{1a8ff9b54377421887b8dd013271701e,
title = "New infusion device for trans-tissue, sustained local delivery of anticancer agent to surgically resected tissue: Potential use for suppression of local recurrence of pancreatic cancer",
abstract = "Local recurrence is a major cause of death of patients who have undergone resection for pancreatic cancer. To reduce the incidence of local recurrence, a new drug-infusion device, which is fixed on resected tissues immediately after surgery, was devised for trans-tissue, sustained local delivery. The drug-infusion device proposed here has the following functions: tight adhesion of the device on resected tissues, sustained drug infusion to the tissue, drug reloading, and easy removal from the body after use. The fabricated prototype experimental device, described here, was a thin infusion pouch made of a thin elastomer film (segmented polyurethane), which is connected to an elastomeric tube for drug reloading. The suppressive effect of the device delivering the anticancer agent, gemcitabine (GEM), was examined using subcutaneous tumor-bearing athymic mouse. A low-dose, local sustained GEM delivery using the device significantly suppressed the tumor growth and regrowth after surgery. The preliminary model experimental result appears to provide a promising therapeutic procedure for increased survival rate of the patients undergoing surgery for pancreatic cancer.",
author = "Tatsuya Manabe and Hidenobu Okino and Ryo Maeyama and Kazuhiro Mizumoto and Masao Tanaka and Takehisa Matsuda",
year = "2005",
month = "4",
day = "1",
doi = "10.1002/jbm.b.30186",
language = "English",
volume = "73",
pages = "203--207",
journal = "Journal of Biomedical Materials Research",
issn = "1552-4973",
publisher = "Heterocorporation",
number = "1",

}

TY - JOUR

T1 - New infusion device for trans-tissue, sustained local delivery of anticancer agent to surgically resected tissue

T2 - Potential use for suppression of local recurrence of pancreatic cancer

AU - Manabe, Tatsuya

AU - Okino, Hidenobu

AU - Maeyama, Ryo

AU - Mizumoto, Kazuhiro

AU - Tanaka, Masao

AU - Matsuda, Takehisa

PY - 2005/4/1

Y1 - 2005/4/1

N2 - Local recurrence is a major cause of death of patients who have undergone resection for pancreatic cancer. To reduce the incidence of local recurrence, a new drug-infusion device, which is fixed on resected tissues immediately after surgery, was devised for trans-tissue, sustained local delivery. The drug-infusion device proposed here has the following functions: tight adhesion of the device on resected tissues, sustained drug infusion to the tissue, drug reloading, and easy removal from the body after use. The fabricated prototype experimental device, described here, was a thin infusion pouch made of a thin elastomer film (segmented polyurethane), which is connected to an elastomeric tube for drug reloading. The suppressive effect of the device delivering the anticancer agent, gemcitabine (GEM), was examined using subcutaneous tumor-bearing athymic mouse. A low-dose, local sustained GEM delivery using the device significantly suppressed the tumor growth and regrowth after surgery. The preliminary model experimental result appears to provide a promising therapeutic procedure for increased survival rate of the patients undergoing surgery for pancreatic cancer.

AB - Local recurrence is a major cause of death of patients who have undergone resection for pancreatic cancer. To reduce the incidence of local recurrence, a new drug-infusion device, which is fixed on resected tissues immediately after surgery, was devised for trans-tissue, sustained local delivery. The drug-infusion device proposed here has the following functions: tight adhesion of the device on resected tissues, sustained drug infusion to the tissue, drug reloading, and easy removal from the body after use. The fabricated prototype experimental device, described here, was a thin infusion pouch made of a thin elastomer film (segmented polyurethane), which is connected to an elastomeric tube for drug reloading. The suppressive effect of the device delivering the anticancer agent, gemcitabine (GEM), was examined using subcutaneous tumor-bearing athymic mouse. A low-dose, local sustained GEM delivery using the device significantly suppressed the tumor growth and regrowth after surgery. The preliminary model experimental result appears to provide a promising therapeutic procedure for increased survival rate of the patients undergoing surgery for pancreatic cancer.

UR - http://www.scopus.com/inward/record.url?scp=16444375053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=16444375053&partnerID=8YFLogxK

U2 - 10.1002/jbm.b.30186

DO - 10.1002/jbm.b.30186

M3 - Article

VL - 73

SP - 203

EP - 207

JO - Journal of Biomedical Materials Research

JF - Journal of Biomedical Materials Research

SN - 1552-4973

IS - 1

ER -